Crescent Capital BDC, Inc. (NASDAQ:CCAP - Get Free Report) has received a consensus rating of "Hold" from the seven brokerages that are covering the stock, Marketbeat Ratings reports. Seven equities research analysts have rated the stock with a hold rating. The average 1-year price target among analysts that have covered the stock in the last year is $11.54.
CCAP has been the topic of several recent research reports. B. Riley Financial reduced their price target on shares of Crescent Capital BDC from $13.50 to $12.50 and set a "neutral" rating on the stock in a report on Wednesday, August 12th. Raymond James Financial set a $10.00 price target on Crescent Capital BDC in a research report on Thursday, October 22nd. Wells Fargo & Company cut their price target on Crescent Capital BDC from $11.00 to $10.00 and set an "equal weight" rating on the stock in a research note on Wednesday, November 11th. Ladenburg Thalmann & Co. Inc. downgraded Crescent Capital BDC from a "buy" rating to a "neutral" rating and set a $10.00 price target for the company. in a report on Wednesday, November 11th. Finally, Keefe, Bruyette & Woods lowered shares of Crescent Capital BDC from an "outperform" rating to a "market perform" rating and lowered their price target for the stock from $13.00 to $12.00 in a research report on Monday, August 17th.
View Our Latest Report on CCAP
Crescent Capital BDC Trading Down 1.7%
NASDAQ:CCAP opened at $9.80 on Friday. The company's 50 day moving average is $9.41 and its two-hundred day moving average is $11.36. The company has a market cap of $361.31 million, a PE ratio of -980.50 and a beta of 0.56. Crescent Capital BDC has a twelve month low of $8.40 and a twelve month high of $15.18.
Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last issued its quarterly earnings results on Monday, November 9th. The company reported $0.37 EPS for the quarter, topping the consensus estimate of $0.35 by $0.02. The company had revenue of $36.89 million during the quarter, compared to analyst estimates of $36.37 million. Crescent Capital BDC had a negative net margin of 0.10% and a positive return on equity of 8.74%. As a group, analysts expect that Crescent Capital BDC will post 1.46 EPS for the current fiscal year.
Crescent Capital BDC Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, January 15th. Investors of record on Thursday, December 31st will be issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 13.9%. The ex-dividend date is Thursday, December 31st. Crescent Capital BDC's payout ratio is -13,600.00%.
Insiders Place Their Bets
In other Crescent Capital BDC news, CEO Jason Breaux bought 5,000 shares of Crescent Capital BDC stock in a transaction dated Tuesday, November 17th. The shares were bought at an average price of $9.98 per share, with a total value of $49,900.00. Following the purchase, the chief executive officer owned 57,636 shares of the company's stock, valued at $575,207.28. This trade represents a 9.50% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, major shareholder & Guaranty Life Insur Fidelity sold 139,054 shares of the stock in a transaction dated Wednesday, September 9th. The stock was sold at an average price of $10.23, for a total value of $1,422,522.42. Following the transaction, the insider owned 3,680,307 shares of the company's stock, valued at approximately $37,649,540.61. This trade represents a 3.64% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 451,543 shares of company stock valued at $4,689,738 over the last ninety days. Insiders own 1.23% of the company's stock.
Institutional Investors Weigh In On Crescent Capital BDC
A number of hedge funds have recently made changes to their positions in the business. Integrated Wealth Concepts LLC purchased a new stake in shares of Crescent Capital BDC in the 2nd quarter valued at $60,000. Beacon Pointe Advisors LLC bought a new stake in shares of Crescent Capital BDC during the second quarter valued at approximately $111,000. Engineers Gate Manager LP bought a new position in shares of Crescent Capital BDC during the 2nd quarter valued at approximately $114,000. SMH Capital Advisors Inc. bought a new stake in shares of Crescent Capital BDC in the 3rd quarter valued at approximately $143,000. Finally, Fifth Third Bancorp bought a new stake in shares of Crescent Capital BDC in the 1st quarter valued at approximately $199,000. 49.46% of the stock is currently owned by institutional investors.
Crescent Capital BDC Company Profile
(
Get Free Report)
Crescent Capital BDC, Inc. is a business development company that provides financing to middle-market businesses. It is externally managed by Crescent Capital Group LP, an alternative credit investment manager. The company invests primarily in debt, including first- and second-lien senior secured loans and subordinated debt, and may also make equity investments. Its portfolio focuses mainly on U.S. companies. Crescent Capital BDC began investment operations in 2015. Through its financing activities, it aims to support the business needs of middle-market companies, including growth and other strategic initiatives.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Crescent Capital BDC, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.
While Crescent Capital BDC currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.